Revvity (NYSE:RVTY) Hits New 12-Month High – What’s Next?

Revvity Inc. (NYSE:RVTY)’s share price hit a new 52-week high on Wednesday . The company traded as high as $125.97 and last traded at $124.9360, with a volume of 51126 shares. The stock had previously closed at $124.84.

Analyst Upgrades and Downgrades

A number of research analysts recently issued reports on RVTY shares. JPMorgan Chase & Co. lowered their target price on shares of Revvity from $96.00 to $90.00 and set a “neutral” rating on the stock in a research note on Wednesday, May 6th. TD Cowen reissued a “buy” rating on shares of Revvity in a research report on Wednesday, July 15th. Stifel Nicolaus decreased their price target on shares of Revvity from $110.00 to $100.00 and set a “hold” rating for the company in a report on Wednesday, May 6th. Robert W. Baird set a $117.00 price target on Revvity in a research report on Wednesday, May 6th. Finally, Barclays lifted their price objective on Revvity from $95.00 to $105.00 and gave the stock an “equal weight” rating in a research note on Thursday, May 7th. Three analysts have rated the stock with a Buy rating and twelve have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $108.36.

Revvity Price Performance

The company has a market cap of $13.97 billion, a price-to-earnings ratio of 59.55, a price-to-earnings-growth ratio of 2.24 and a beta of 1.07. The company has a current ratio of 1.80, a quick ratio of 1.50 and a debt-to-equity ratio of 0.36. The company has a fifty day moving average price of $112.37 and a two-hundred day moving average price of $100.63.

Revvity (NYSE:RVTY) last issued its earnings results on Tuesday, August 4th. The company reported $1.41 EPS for the quarter, beating analysts’ consensus estimates of $1.21 by $0.20. The business had revenue of $729.69 million during the quarter, compared to analyst estimates of $702.96 million. Revvity had a return on equity of 8.34% and a net margin of 8.16%.Revvity’s revenue was down 1.3% on a year-over-year basis. During the same period in the prior year, the company posted $1.18 earnings per share. Revvity has set its FY 2026 guidance at 5.300-5.400 EPS. As a group, equities research analysts anticipate that Revvity Inc. will post 5.36 EPS for the current fiscal year.

Revvity Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 13th. Stockholders of record on Friday, October 23rd will be paid a $0.07 dividend. The ex-dividend date is Friday, October 23rd. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.2%. Revvity’s dividend payout ratio is currently 13.33%.

Hedge Funds Weigh In On Revvity

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. California State Teachers Retirement System grew its holdings in shares of Revvity by 19.8% in the 1st quarter. California State Teachers Retirement System now owns 133,809 shares of the company’s stock worth $11,723,000 after purchasing an additional 22,075 shares during the last quarter. Corient Private Wealth LLC boosted its position in Revvity by 985.0% in the fourth quarter. Corient Private Wealth LLC now owns 126,568 shares of the company’s stock valued at $12,245,000 after buying an additional 114,903 shares in the last quarter. Diamond Hill Capital Management Inc. grew its stake in Revvity by 6.3% during the fourth quarter. Diamond Hill Capital Management Inc. now owns 426,899 shares of the company’s stock worth $41,302,000 after buying an additional 25,233 shares during the last quarter. Bank of America Corp DE increased its holdings in shares of Revvity by 14.7% during the first quarter. Bank of America Corp DE now owns 880,503 shares of the company’s stock worth $77,141,000 after buying an additional 112,928 shares in the last quarter. Finally, Tocqueville Asset Management L.P. bought a new position in shares of Revvity in the second quarter valued at approximately $4,791,000. 86.65% of the stock is owned by institutional investors.

Revvity Company Profile

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.